These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Aziz DE; Abdelbary AA; Elassasy AI Drug Deliv; 2018 Nov; 25(1):815-826. PubMed ID: 29557244 [TBL] [Abstract][Full Text] [Related]
23. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin. Thakkar HP; Savsani H; Kumar P Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414 [TBL] [Abstract][Full Text] [Related]
24. Serum theophylline after multiple dosing with transdermal gels in cats. Barnoski J; Lee-Fowler TM; Boothe DM; Behrend EN J Feline Med Surg; 2019 Apr; 21(4):329-334. PubMed ID: 29807504 [TBL] [Abstract][Full Text] [Related]
25. Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner. Lavan RP; Armstrong R; Newbury H; Normile D; Hubinois C Open Vet J; 2021; 11(3):458-467. PubMed ID: 34722211 [TBL] [Abstract][Full Text] [Related]
26. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic benefits of natural oils along with permeation enhancing activity. Amra K; Momin M; Desai N; Khan F Int J Dermatol; 2022 Apr; 61(4):484-507. PubMed ID: 34310695 [TBL] [Abstract][Full Text] [Related]
28. Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA. Lavan R; Armstrong R; Normile D; Vaala W Parasit Vectors; 2020 Oct; 13(1):541. PubMed ID: 33129346 [TBL] [Abstract][Full Text] [Related]
29. Transdermal delivery of metoprolol. II: In-vitro skin permeation and bioavailability in hairless rats. Ghosh TK; Adir J; Xiang SL; Onyilofur S J Pharm Sci; 1995 Feb; 84(2):158-60. PubMed ID: 7738793 [TBL] [Abstract][Full Text] [Related]
30. Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time. Heustess A; Spigener S; Sweitzer S; Romero-Sandoval A; Asbill S Int J Pharm Compd; 2015; 19(2):167-73. PubMed ID: 26685497 [TBL] [Abstract][Full Text] [Related]
31. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation. Aggarwal G; Dhawan S; HariKumar SL Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211 [TBL] [Abstract][Full Text] [Related]
32. To compound or not to compound: a veterinary transdermal discussion. Eichstadt LR; Davidson GS Int J Pharm Compd; 2014; 18(5):366-9. PubMed ID: 25577884 [TBL] [Abstract][Full Text] [Related]
33. Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects. Zhou B; Liu S; Yin H; Qi M; Hong M; Ren GB Eur J Pharm Sci; 2021 Sep; 164():105915. PubMed ID: 34146681 [TBL] [Abstract][Full Text] [Related]
34. A survey of Italian cat owners' attitudes towards cat vaccination through a web-based questionnaire. Filipe JFS; Lauzi S; Pina L; Dall'Ara P BMC Vet Res; 2021 Aug; 17(1):267. PubMed ID: 34372835 [TBL] [Abstract][Full Text] [Related]
35. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery. Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959 [TBL] [Abstract][Full Text] [Related]
36. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention. Tian Q; Quan P; Fang L; Xu H; Liu C Int J Pharm; 2021 Oct; 608():121082. PubMed ID: 34506925 [TBL] [Abstract][Full Text] [Related]
37. Boosting transdermal delivery of atorvastatin calcium via o/w nanoemulsifying system: Two-step optimization, ex vivo and in vivo evaluation. Shaker DS; Ishak RAH; Elhuoni MA; Ghoneim AM Int J Pharm; 2020 Mar; 578():119073. PubMed ID: 31982556 [TBL] [Abstract][Full Text] [Related]
38. Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment. Nagai N; Ogata F; Otake H; Nakazawa Y; Kawasaki N Int J Nanomedicine; 2018; 13():5215-5229. PubMed ID: 30233182 [TBL] [Abstract][Full Text] [Related]
39. Permeation enhancer strategies in transdermal drug delivery. Marwah H; Garg T; Goyal AK; Rath G Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687 [TBL] [Abstract][Full Text] [Related]
40. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics. Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]